Multi-Center Study of Thromboplastin Calibration Precision – Influence of Reagent Species, Composition, and International Sensitivity Index (ISI)

Summary

Four thromboplastin reagents were tested by 18 laboratories in Europe, North-America, and Australasia, according to a detailed protocol. One thromboplastin was the International Reference Preparation for ox brain thromboplastin combined with adsorbed bovine plasma (coded OBT/79), and the second was a certified reference material for rabbit brain thromboplastin, plain (coded CRM 149R). The other two thromboplastin reagents were another rabbit plain brain thromboplastin (RP) with a lower ISI than CRM 149R and a rabbit brain thromboplastin combined with adsorbed bovine plasma (RC). Calibration of the latter two reagents was performed according to methods recommended by the World Health Organization (W. H. O.).

The purpose of this study was to answer the following questions: 1) Is the calibration of the RC reagent more precise against the bovine/combined (OBT/79) than against the rabbit/plain reagent (CRM 149R)? 2) Is the precision of calibration influenced by the magnitude of the International Sensitivity Index (ISI)?

The lowest inter-laboratory variation of ISI was observed in the calibration of the rabbit/plain reagent (RP) against the other rabbit/plain reagent (CRM 149R) (CV 1.6%). The highest interlaboratory variation was obtained in the calibration of rabbit/plain (RP) against bovine/combined (OBT/79) (CV 5.1%). In the calibration of the rabbit/combined (RC) reagent, there was no difference in precision between OBT/79 (CV 4.3%) and CRM 149R (CV 4.2%). Furthermore, there was no significant difference in the precision of the ISI of RC obtained with CRM 149R (ISI = 1.343) and the rabbit/plain (RP) reagent with ISI = 1.14. In conclusion, the calibration of RC could be performed with similar precision with either OBT/79 or CRM 149R, or RP.

The mean ISI values calculated with OBT/79 and CRM 149R were practically identical, indicating that there is no bias in the ISI of these reference preparations and that these reference preparations have been stable since their original calibration studies in 1979 and 1987, respectively.

International Normalized Ratio (INR) equivalents were calculated for a lyophilized control plasma derived from patients treated with oral anticoagulants. There were small but significant differences in the mean INR equivalents between the bovine and rabbit thromboplastins. There were no differences in the interlaboratory variation of the INR equivalents, when the four thromboplastins were compared.

• References

• 1 WHO Expert Committee on Biological Standardization. Thirty-third Report. WHO Tech Rep Ser 1983; 687: 81-105
• 2 Loeliger EA. International Committee for Standardization in Haematology and International Committee on Thrombosis and Haemostasis. ICSH/ICTH recommendations for reporting prothrom-bin time in oral anticoagulant control. Thromb Haemostas 1985; 53: 155-156
• 3 Hermans J, Van den Besselaar AMHP, Loeliger EA, Van der Velde EA. A collaborative calibration study of reference materials for thromboplastins. Thromb Haemostas 1983; 50: 712-717
• 4 Thomson JM, Tomenson JA, Poller L. The calibration of the second primary international reference preparation for thromboplastin (thromboplastin, human, plain, coded BCT/253). Thromb Haemostas 1984; 52: 336-342
• 5 Loeliger EA, Van den Besselaar AMHP, Lewis SM. Reliability and clinical impact of the Normalization of the Prothrombin Times in Oral Anticoagulant Control. Thromb Haemostas 1985; 53: 148-154
• 6 Van den Besselaar AMHP, Bertina RM. Multi-center calibration of the second reference material for thromboplastin, rabbit, plain, coded CRM 149R. Thromb Haemostas 1991; 65: 263-267
• 7 Taberner DA, Poller L, Thomson JM, Darby KV. Effect of international sensitivity index (ISI) of thromboplastins on precision of international normalised ratios (INR). J Clin Pathol 1989; 42: 92-96
• 8 Wissenschaftliche Tabellen. Teilband Statistik. 8 Auflage Geigy, Basel 1980 par. 13B 206-207 and Table A, 51
• 9 Reijnierse GLA, Van den Besselaar AMHP, Hermans J. Een nieuw verwerkingsprogramma van ingezonden uitslagen in het kader van externe kwaliteitsbewaking. Ervaringen in 1988. Tijdschr NVKC 1989; 14: 122-127
• 10 Steigstra H, Jansen RTP, Baadenhuijsen H. Combi Scheme: New combined internal/external quality-assessment scheme in The Netherlands. Clin Chem 1991; 37: 1196-1204
• 11 Tomenson JA. A statistician's independent evaluation. In: Thromboplastin Calibration and oral Anticoagulant Control. Van Van den Besselaar AMHP. et al. (eds). Martinus Nijhoff Publishers; Boston: 87-108 1984
• 12 Van den Besselaar AMHP, Van Halem-Visser LP, Hoekstra-Schuman M, Van der Marel-van Nieuwkoop W, Loeliger EA. Simplified Thromboplastin Calibration. Further experience of the Dutch Reference Laboratory for Anticoagulant Control. Thromb Haemostas 1980; 43: 53-57
• 13 Van den Besselaar AMHP, Hermans J, Beeser H, Loeliger EA. Long-term stability of international reference preparations for thromboplastins. Br J Haematol 1988; 68: 321-328
• 14 Ingram GIC. The stability of the WHO Reference Thromboplastin NIBS & C 67/40. Thromb Haemostas 1979; 42: 1135-1140
• 15 Kitchen S, Malia RG, Greaves M, Preston FE. A method for the determination of activated factor VII using bovine and rabbit brain thromboplastins: demonstration of increased levels in disseminated intravascular coagulation. Thromb Res 1988; 50: 191-200